Literature DB >> 1580819

Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect.

K B Boone1, B L Miller, I M Lesser, C M Mehringer, E Hill-Gutierrez, M A Goldberg, N G Berman.   

Abstract

The clinical significance of white-matter lesions (WMLs) detected by computed tomography and magnetic resonance imaging in healthy elderly subjects has been controversial, with some studies reporting associated deficits in cognition and others failing to document cognitive disturbance. In our sample of 100 healthy elderly individuals, almost half (n = 46) had no WMLs, approximately one fourth had minimal (less than or equal to 1 cm2; n = 27) or moderate (greater than 1 cm2 but less than or equal to 10 cm2; n = 21) WML areas, and six subjects had large WML areas (greater than 10 cm2). Substantial disturbances in basic attention and selected frontal lobe skills were detected in the six subjects with the large WML areas. These findings suggest that a "threshold" of WML area must be present before cognitive deficits are observed. Surprisingly, no significant relationships between duration of hypertension or cholesterol levels and WMLs were detected, suggesting that factors other than vascular disturbances are involved in the origin of at least some WMLs.

Entities:  

Mesh:

Year:  1992        PMID: 1580819     DOI: 10.1001/archneur.1992.00530290141024

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  66 in total

1.  White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging.

Authors:  R Barber; P Scheltens; A Gholkar; C Ballard; I McKeith; P Ince; R Perry; J O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

2.  Long term effects of refractory temporal lobe epilepsy on cognitive abilities: a cross sectional study.

Authors:  H Jokeit; A Ebner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

3.  Regional and global changes in cerebral diffusion with normal aging.

Authors:  A O Nusbaum; C Y Tang; M S Buchsbaum; T C Wei; S W Atlas
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 4.  The neuropsychiatry of subcortical ischemic brain disease.

Authors:  D Feil; A Kumar
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

5.  MRI signal hyperintensities and treatment remission of geriatric depression.

Authors:  Faith M Gunning-Dixon; Michael Walton; Janice Cheng; Jessica Acuna; Sibel Klimstra; Molly E Zimmerman; Adam M Brickman; Matthew J Hoptman; Robert C Young; George S Alexopoulos
Journal:  J Affect Disord       Date:  2010-05-07       Impact factor: 4.839

6.  Simultaneous analysis of plasma and CSF by NMR and hierarchical models fusion.

Authors:  Agnieszka Smolinska; Joram M Posma; Lionel Blanchet; Kirsten A M Ampt; Amos Attali; Tinka Tuinstra; Theo Luider; Marek Doskocz; Paul J Michiels; Frederic C Girard; Lutgarde M C Buydens; Sybren S Wijmenga
Journal:  Anal Bioanal Chem       Date:  2012-03-07       Impact factor: 4.142

Review 7.  Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review.

Authors:  John L Beyer; Robert Young; Maragatha Kuchibhatla; K Ranga R Krishnan
Journal:  Int Rev Psychiatry       Date:  2009

Review 8.  Neuroradiological findings in vascular dementia.

Authors:  Ali Guermazi; Yves Miaux; Alex Rovira-Cañellas; Joyce Suhy; Jon Pauls; Ria Lopez; Holly Posner
Journal:  Neuroradiology       Date:  2006-11-18       Impact factor: 2.804

Review 9.  Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Authors:  Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Effect of white matter disease on functional connections in the aging brain.

Authors:  A F Leuchter; J J Dunkin; R B Lufkin; Y Anzai; I A Cook; T F Newton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.